Active ingredientDoravirineCat. No. P-D173-001CAS 1338225-97-0Family · Pharmaceutical analytical standards
Doravirine
An antiretroviral of the non-nucleoside reverse transcriptase inhibitor (NNRTI) class, approved in the United States in August 2018 for HIV-1, on its own or in a single tablet together with lamivudine and tenofovir. This family brings together the active ingredient, labelled standards and nitrosamines.
Did you know?In laboratory tests it remains active against some common HIV mutations that cause NNRTI resistance, such as K103N, Y181C and G190A.
Go to the active ingredient →Active ingredientDoravirineCat. No. P-D173-001CAS 1338225-97-0
Isotopically labelledDoravirine-13C-d3Cat. No. P-D173-002
NitrosamineN1-Nitroso DoravirineCat. No. P-D173-004No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.